2021年至2024年美国特应性皮炎患病率：来自国家健康访谈调查的数据。 - Suppr | 超能文献

Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey.

作者信息

Chan Kaitlyn R, Keddie Suzanne H, Flohr Carsten, Tsoi Man Fung

机构信息

Unit of Paediatric & Population-Based Dermatology Research, St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; Global Atopic Dermatitis Atlas Coordinating Centre, St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.

Unit of Paediatric & Population-Based Dermatology Research, St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom; Global Atopic Dermatitis Atlas Coordinating Centre, St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom.

出版信息

J Am Acad Dermatol. 2025 Oct 6. doi: 10.1016/j.jaad.2025.10.022.

DOI:10.1016/j.jaad.2025.10.022

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Prevalence of atopic dermatitis in the United States from 2021 to 2024: Data from the National Health Interview Survey.2021年至2024年美国特应性皮炎患病率：来自国家健康访谈调查的数据。

J Am Acad Dermatol. 2025 Oct 6. doi: 10.1016/j.jaad.2025.10.022.

2

Magnitude of atopic dermatitis and associated factors among children in northwest Ethiopia.埃塞俄比亚西北部儿童特应性皮炎的严重程度及相关因素

Sci Rep. 2025 Jul 30;15(1):27882. doi: 10.1038/s41598-025-09612-9.

3

Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.阿布昔替尼、特利鲁单抗和乌帕替尼治疗中重度特应性皮炎。

Health Technol Assess. 2024 Jan;28(4):1-113. doi: 10.3310/LEXB9006.

4

Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.在一项开放性研究中，度普利尤单抗为中重度特应性皮炎成人患者提供了长达 4 年的可接受安全性和持续疗效。

Am J Clin Dermatol. 2022 May;23(3):393-408. doi: 10.1007/s40257-022-00685-0. Epub 2022 May 3.

5

Habitual Scratching in Atopic Dermatitis and Its Association with Disease Severity: Findings from Japanese Health Insurance Claims and App-Based Data.特应性皮炎中的习惯性搔抓及其与疾病严重程度的关联：来自日本医疗保险理赔和基于应用程序数据的研究结果

Dermatol Ther (Heidelb). 2025 Aug 21. doi: 10.1007/s13555-025-01525-9.

6

The socioeconomic impact of atopic dermatitis in the United States: a systematic review.美国特应性皮炎的社会经济影响：一项系统综述。

Pediatr Dermatol. 2008 Jan-Feb;25(1):1-6. doi: 10.1111/j.1525-1470.2007.00572.x.

7

Prenatal exposure to environmental bisphenols over time and their association with childhood asthma, allergic rhinitis and atopic dermatitis in the ECHO consortium.ECHO联盟中孕期长期暴露于环境双酚及其与儿童哮喘、过敏性鼻炎和特应性皮炎的关联

Environ Pollut. 2025 Feb 1;366:125415. doi: 10.1016/j.envpol.2024.125415. Epub 2024 Nov 28.

8

Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies.芦可替尼乳膏单药治疗改善了轻至中度特应性皮炎成人和青少年的症状及生活质量：两项III期研究的患者报告结果

Am J Clin Dermatol. 2025 Jan;26(1):121-137. doi: 10.1007/s40257-024-00901-z. Epub 2024 Nov 15.

9

Global, regional, and national burdens of atopic dermatitis from 1990 to 2021: A trend analysis from the Global Burden of Disease Study 2021.1990年至2021年全球、区域和国家特应性皮炎负担：全球疾病负担研究2021的趋势分析

J Am Acad Dermatol. 2025 Oct;93(4):1008-1017. doi: 10.1016/j.jaad.2025.06.042. Epub 2025 Jun 19.

10

Epidemiological characteristics of inhaled allergens influenced by plum rains and diagnostic value of neutrophil to lymphocyte ratio in atopic dermatitis patients.梅雨对吸入性变应原流行病学特征的影响及中性粒细胞与淋巴细胞比值在特应性皮炎患者中的诊断价值

Medicine (Baltimore). 2025 Oct 10;104(41):e44866. doi: 10.1097/MD.0000000000044866.

引用本文的文献

1

Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.口服米诺地尔治疗脱发：风险、益处及建议。

Am J Clin Dermatol. 2025 Oct 21. doi: 10.1007/s40257-025-00990-4.